Mark Parrington

Person

Bradford, CA

People

Patents Grantslast 30 patents

Information Patent Grant
Replication-defective flavivirus vaccines and vaccine vectors
- Patent number 9,217,158
- Issue date Dec 22, 2015
- Sanofi Pasteur Biologics, LLC
- Konstantin V. Pugachev
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tumor antigens BFA4 and BCY1 for prevention and / or treatment of c...
- Patent number 8,946,174
- Issue date Feb 3, 2015
- Sanofi Pasteur Limited
- Neil Berinstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multi-antigen vectors of melanoma
- Patent number 8,911,991
- Issue date Dec 16, 2014
- Sanofi Pasteur Limited
- Neil Berinstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified CEA/B7 vector
- Patent number 8,562,970
- Issue date Oct 22, 2013
- Sanofi Pasteur Limited
- Mark Parrington
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified CEA nucleic acid and expression vectors
- Patent number 8,530,442
- Issue date Sep 10, 2013
- Sanofi Pasteur Limited
- Mark Parrington
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified CEA nucleic acid and expression vectors
- Patent number 8,236,776
- Issue date Aug 7, 2012
- Sanofi Pasteur Limited
- Mark Parrington
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tumor antigens for prevention and/or treatment of cancer
- Patent number 8,207,314
- Issue date Jun 26, 2012
- Sanofi Pasteur Limited
- Neil Berinstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tumor antigens Bfa5 for prevention and/or treatment of cancer
- Patent number 8,021,664
- Issue date Sep 20, 2011
- Sanofi Pasteur Limited
- Neil Berinstein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tumor antigens BFA4 and BCY1 for prevention and / or treatment of c...
- Patent number 7,851,213
- Issue date Dec 14, 2010
- Sanofi Pasteur Limited
- Neil Berinstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified CEA nucleic acid and expression vectors
- Patent number 7,786,278
- Issue date Aug 31, 2010
- Sanofi Pasteur Limited
- Mark Parrington
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Expressing gp140 fragment of primary HIV-1 isolate
- Patent number 7,220,826
- Issue date May 22, 2007
- Sanofi Pasteur Limited
- Charles D. Y. Sia
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Alphavirus vectors for paramyxovirus vaccines
- Patent number 6,475,780
- Issue date Nov 5, 2002
- Aventis Pasteur Limited
- Mark Parrington
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RNA respiratory syncytial virus vaccines
- Patent number 6,428,324
- Issue date Aug 6, 2002
- Aventis Pateur Limited
- Mark Parrington
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
RNA respiratory syncytial virus vaccines
- Patent number 6,060,308
- Issue date May 9, 2000
- Connaught Laboratories Limited
- Mark Parrington
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
MODIFIED CEA NUCLEIC ACID AND EXPRESSION VECTORS
- Publication number 20130101625
- Publication date Apr 25, 2013
- Mark Parrington
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Tumor Antigens for the Prevention and/or Treatment of Cancer
- Publication number 20130011422
- Publication date Jan 10, 2013
- Neil Berinstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Replication-Defective Flavivirus Vaccine Vectors Against Respirator...
- Publication number 20120128713
- Publication date May 24, 2012
- SANOFI PASTEUR LIMITED
- Konstantin V. Pugachev
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Tumor Antigens BFA5 for Prevention and/or Treatment of Cancer
- Publication number 20110311543
- Publication date Dec 22, 2011
- Neil Berinstein
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TUMOR ANTIGENS BFA4 AND BCY1 FOR PREVENTION AND / OR TREATMENT OF C...
- Publication number 20110117640
- Publication date May 19, 2011
- Aventis Pasteur, Ltd.
- Neil Berinstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED CEA NUCLEIC ACID AND EXPRESSION VECTORS
- Publication number 20100285065
- Publication date Nov 11, 2010
- Mark Parrington
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TUMOR ANTIGEN BFY3 FOR PREVENTION AND/OR TREATMENT OF CANCER
- Publication number 20100278848
- Publication date Nov 4, 2010
- Aventis Pasteur, Inc.
- Neil Berinstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Modified KSA and Uses Thereof
- Publication number 20090156519
- Publication date Jun 18, 2009
- Aventis Pasteur, Inc.
- Neil Berinstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Tumor Antigens Bfa5 For Prevention And/Or Treatment Of Cancer
- Publication number 20080138365
- Publication date Jun 12, 2008
- Neil Berinstein
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Modified Cea/B7 Vector
- Publication number 20080113928
- Publication date May 15, 2008
- Mark Parrington
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Multi-antigen vectors of melanoma
- Publication number 20060127360
- Publication date Jun 15, 2006
- Aventis Pasteur, Ltd.
- Neil Berinstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Tumor antigen BFA5 for prevention and / or treatment of cancer
- Publication number 20050112099
- Publication date May 26, 2005
- Aventis Pasteur, Ltd.
- Neil Berinstein
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Immunogenic compositions comprising an antigen and a purified m pro...
- Publication number 20050037015
- Publication date Feb 17, 2005
- Brain Barber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Tumor antigens BFA4 and BCY1 for prevention and / or treatment of c...
- Publication number 20040197912
- Publication date Oct 7, 2004
- Aventis Pasteur, Ltd.
- Neil Berinstein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Mark Parrington

Person

Patents Grantslast 30 patents

Replication-defective flavivirus vaccines and vaccine vectors

Tumor antigens BFA4 and BCY1 for prevention and / or treatment of c...

Multi-antigen vectors of melanoma

Modified CEA/B7 vector

Modified CEA nucleic acid and expression vectors

Modified CEA nucleic acid and expression vectors

Tumor antigens for prevention and/or treatment of cancer

Tumor antigens Bfa5 for prevention and/or treatment of cancer

Tumor antigens BFA4 and BCY1 for prevention and / or treatment of c...

Modified CEA nucleic acid and expression vectors

Expressing gp140 fragment of primary HIV-1 isolate

Alphavirus vectors for paramyxovirus vaccines

RNA respiratory syncytial virus vaccines

RNA respiratory syncytial virus vaccines

Patents Applicationslast 30 patents

MODIFIED CEA NUCLEIC ACID AND EXPRESSION VECTORS

Tumor Antigens for the Prevention and/or Treatment of Cancer

Replication-Defective Flavivirus Vaccine Vectors Against Respirator...

Tumor Antigens BFA5 for Prevention and/or Treatment of Cancer

TUMOR ANTIGENS BFA4 AND BCY1 FOR PREVENTION AND / OR TREATMENT OF C...

MODIFIED CEA NUCLEIC ACID AND EXPRESSION VECTORS

TUMOR ANTIGEN BFY3 FOR PREVENTION AND/OR TREATMENT OF CANCER

Modified KSA and Uses Thereof

Tumor Antigens Bfa5 For Prevention And/Or Treatment Of Cancer

Modified Cea/B7 Vector

Multi-antigen vectors of melanoma

Tumor antigen BFA5 for prevention and / or treatment of cancer

Immunogenic compositions comprising an antigen and a purified m pro...

Tumor antigens BFA4 and BCY1 for prevention and / or treatment of c...